Two FDA Vaccine Leaders Resigned
Translated by: Ben Edwards
Marion Gruber, director of the FDA’s Office of Vaccines Research & Review, will resign by the end of October, and Phil Krause, deputy director of the vaccine office, will also resign by the end of November, according to Endpoint News.
This office is responsible for the work of vaccine review, including Pfizer Comirnaty COVID-19 (CCP virus) vaccine.
According to this report, a former senior FDA leader disclosed that the two leaders will resign, because they were dissatisfied with the Centers for Disease Control and Prevention (CDC) and its subsidiary, Advisory Committee on Immunization Practices (ACIP), for deprivation of decision-making powers. They believed that these decision-making powers should be led by FDA. The former senior FDA leader also said that the two leaders were disappointed by some officials in the FDA and accused the White House and CDC for excessive intervention in facilitating the ‘booster vaccination’.
It is reported that the Biden administration is promoting the vaccination against CCP virus vigorously, enjoying the advantage of “vaccine politics” and transferring risks and responsibilities to CDC and FDA. Miles Guo’s live broadcasts on ‘vaccine’ have focused on the essence of the CCP virus and its vaccine in the past two weeks. Nevertheless, It is obvious that there is divergence in medical and health regulatory agencies of the U.S. on the issue of the CCP vaccine. The vaccine disaster will end sooner or later.
Posted by: Malaca
More information, follow us